Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Ceftazidime Avibactam plus
Metronidazole compared to Meropenem for treating hospitalized patients with complicated
intra-abdominal infections.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca Pfizer
Treatments:
Avibactam Avibactam, ceftazidime drug combination Ceftazidime Meropenem Metronidazole Thienamycins